Patents
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
03/2000
03/08/2000CN1246861A Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds
03/07/2000US6034256 Substituted benzopyran derivatives for the treatment of inflammation
03/07/2000US6034255 Inhibitors of cholesterol esterase
03/07/2000US6034244 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
03/07/2000US6034242 2,4-pentadienoic acid derivatives having retinoid-like biological activity
03/07/2000US6034121 Agriculture
03/07/2000US6034095 Rheumatic diseases; osteoporosis
03/07/2000US6033714 Process for production of isoflavone fractions from soy
03/02/2000WO2000010994A1 Process for the preparation of 2-(aryloxymethyl)-2,5,7,8-tetramethylchroman-6-ols
03/02/2000WO2000010993A1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
03/02/2000WO2000010992A2 Water-dispersible or water-soluble d-tocotrienol compounds and methods for making therefor
03/01/2000EP0982307A2 9 -Amino- and 9-nitro-camptothecin derivatives, process for their preparation and use as antitumor agents
03/01/2000EP0673374B1 Pharmaceutical composition containing bicyclic type compounds
02/2000
02/29/2000US6031105 Substituted pyridines
02/29/2000US6030951 For treating tumors in mammals
02/29/2000US6030841 Processing series of blood samples obtained at timed intervals after intravenous injection of colored/fluorescent bile acid derivative to obtain plasma, measuring color or fluorescence, fitting to plasma elimination curve, comparing
02/29/2000CA2117349C Benzopyrans and related ltb4 antagonists
02/24/2000WO2000009493A1 Enantioselective synthesis
02/24/2000WO2000009116A1 Grp receptor ligands
02/23/2000EP0980535A1 Photochromic compositions, photochromic compounds (co)polymers matrices
02/23/2000EP0980365A1 Alpha-tocopherol 4-aminobenzoic acid ester compounds and method for preparing the same
02/23/2000EP0980364A1 Process for preparing coumarin sulfonates
02/23/2000EP0980363A1 Preparation of isoflavones from legumes
02/23/2000CN1245430A Prophylactic and therapeutic agent for inflammatory intestinal diseases
02/23/2000CN1245429A Leukotriene antagonists for oral squamous cell carcinoma
02/23/2000CN1049657C Process for preparing substituted benzopyran derivatives
02/22/2000US6028100 Dihalopropene compounds, insecticides containing them as active ingredients, and intermediates for their production
02/22/2000US6028052 Treating NIDDM with RXR agonists
02/17/2000WO2000008033A1 Water soluble prodrugs of hindered alcohols or phenols
02/17/2000WO2000008010A1 Sesterterpene derivatives exhibiting antifungal activities
02/17/2000WO2000008009A1 Process for the preparation of 2-(aminophenoxymethyl) chromans
02/17/2000WO2000007979A2 Compounds and compositions for delivering active agents
02/17/2000WO2000007978A1 Aminomethylcarboxylic acid derivatives
02/17/2000CA2339291A1 Sesterterpene derivatives exhibiting antifungal activities
02/16/2000EP0979107A1 Light imaging contrast agents
02/16/2000EP0979103A1 Compounds
02/16/2000CN1244863A Novel benzopyran derivatives
02/15/2000US6025505 Fluorescent labeling probes for immunoassays, dna sequencing, detecting products of polymerase chain reactions
02/15/2000US6025387 Gastroprotective flavone/flavanone compounds with therapeutic effect on inflammatory bowel disease
02/15/2000US6025381 3,4-(diphenyl)chromans
02/10/2000WO2000006085A2 Compounds and methods
02/10/2000WO2000000489A3 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands
02/10/2000CA2338697A1 Compounds and methods
02/09/2000EP0977749A1 Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same
02/09/2000EP0977748A1 Substituted benzopyran derivatives for the treatment of inflammation
02/09/2000EP0977747A1 Photoactive coumarin derivatives
02/08/2000US6022888 Iridoid derivatives and neovascularization inhibitors containing the same as active ingredient
02/08/2000US6022731 Genetically engineered plasmid that expresses a synthetases which is useful in producing copmounds that function as antibiotics, antitumor agents, or immunosuppressants
02/08/2000US6022496 Chromene compound
02/03/2000WO2000004914A1 Novel fluorescence dyes and their applications for whole cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof
02/03/2000WO2000004892A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions
02/03/2000WO1999057107A3 Cannabinoids selective for the cb2 receptor
02/03/2000CA2335062A1 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions
02/02/2000EP0977035A2 A system for determining the electrical potential across a membrane
02/02/2000EP0976398A2 Use of 3,4-diphenyl chroman derivatives in the manufacture of a medicament for lowering serum cholesterol levels and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
02/02/2000EP0975619A1 INTENSE COLOURING PHOTOCHROMIC 2$i(H)-NAPHTHO 1,2-$i(b)]PYRANS AND HETEROCYCLIC PYRANS
02/02/2000EP0975618A1 A new process
02/02/2000EP0975617A1 Inhibitors of cholesterol esterase
02/02/2000CN1243511A Preparation of -3,4-dicarboxylic anhydrides
02/02/2000CN1048910C Method for fine still separation of mixture sensitive to air and/or temp., and tower thereof
02/01/2000US6020505 Process for the preparation of α-tocopherol
02/01/2000US6020504 Process for the preparation of chroman derivatives
02/01/2000US6020481 Fluorescent labeling reagents; dideoxy polynucleotide sequencing and fragment analysis methods.
02/01/2000US6020364 Compounds and method of treating psychosis and schizophrenia
02/01/2000US6020363 Isocoumarin derivatives and use thereof in drugs
02/01/2000US6020362 Glycoprotein IIB IIIA antagonists
01/2000
01/27/2000WO2000004011A1 Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process
01/27/2000WO2000004008A1 Novel cyp2d fluorescent assay reagents
01/27/2000WO2000003707A1 Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents
01/27/2000WO2000003706A1 Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents
01/27/2000WO2000003681A2 Process for the synthesis of benzopyran derivatives
01/27/2000CA2337481A1 Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process
01/27/2000CA2337256A1 Isoflavonoid-based therapeutic composition intended to be used in the treatment of tumours with cytotoxic agents
01/27/2000CA2337179A1 Therapeutic composition based on flavonoids, intended to be used in the treatment of tomours by cytotoxic
01/26/2000EP0973763A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
01/26/2000EP0973761A1 RED COLOURING HYPERCHROMIC 3$i(H)-NAPHTHO 2,1-$i(b)]PYRANS
01/26/2000EP0973727A2 Activated iododerivatives for the treatment of cancer and aids
01/26/2000EP0973516A1 Use of halo and/or nitro-substituted flavonoids as anxyolitics
01/26/2000EP0670839B1 Process for the preparation of 9-amino camptothecin
01/26/2000CN1048724C Process for extracting total flavone from ginkgo leaf
01/26/2000CN1048723C Method for preparing benzopyran derivative
01/25/2000US6018062 17-difluoromethylene-estratrienes
01/25/2000US6017768 For screening agonists or antagonists of alpha adrenergic receptors, dopamine receptors, sigma opiate receptors, potassium ion channels, carbonic anhydrase inhibitors; for treatment of glaucoma
01/25/2000US6017675 Polymerization catalyst
01/20/2000WO2000002860A1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
01/20/2000WO2000002850A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators
01/20/2000CA2337258A1 2-aminopyridine derivatives, their use as medicines and pharmaceutical compositions containing them
01/19/2000EP0971914A2 NEUTRAL COLOURING PHOTOCHROMIC 2$i(H)-NAPHTHO 1,2-$i(b)]PYRANS AND HETEROCYCLIC PYRANS
01/19/2000EP0971854A1 Novel materials useful as electrolytic solutes
01/19/2000EP0971695A1 Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions
01/19/2000CN1242009A (Benzofuran) naphthopyrans, the compositions and (CO) polymer matrices containing them
01/19/2000CN1241623A Supercritical carbon dioxide extraction process of grape seed oil and cyanine oligomer
01/19/2000CN1241566A Process for preparing d, I-apha-tocopherol
01/19/2000CN1048489C Novel anti-virus compound methyl brevifolin carboxylic ester and method for prepn. of same
01/19/2000CN1048488C Novel compound for anti-virus and method for prepn. of same
01/18/2000US6015834 Administering chelate compound; antiischemic, antiepileptic, and wound healing agents; treating brain and nervous system disorders
01/13/2000WO2000001686A1 Method of producing vitamin e
01/13/2000WO2000001685A1 Preparation of tocopherols
01/13/2000WO2000001666A1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES
01/13/2000WO2000001663A1 Novel fluorescent lanthanide chelates